Prognostic Importance of Atrial Fibrillation and Anticoagulation in Alcoholic Versus Dilated Cardiomyopathy

Alan Manivannan1, Morten Schou2, Kevin M Monahan2

  • 1Department of Medicine, Section of Internal Medicine, Boston University Medical Center, Boston, MA, USA.

Insights

Patients with alcoholic cardiomyopathy (ACM) face a worse prognosis than those with dilated cardiomyopathy (DCM), irrespective of atrial fibrillation (AF). Oral anticoagulation offers similar benefits for both ACM and DCM patients.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Pharmacology

Background:

  • Alcoholic cardiomyopathy (ACM) and dilated cardiomyopathy (DCM) are significant heart conditions.
  • Atrial fibrillation (AF) is a common comorbidity in cardiac diseases.
  • Limited data exist on the comparative prognosis of AF and oral anticoagulation in ACM versus DCM.

Purpose of the Study:

  • To compare the prognostic impact of atrial fibrillation (AF) in patients with alcoholic cardiomyopathy (ACM) versus dilated cardiomyopathy (DCM).
  • To assess the effectiveness of oral anticoagulation in patients with ACM compared to DCM.
  • To investigate mortality differences following anticoagulation initiation in both ACM and DCM populations.

Main Methods:

  • A nationwide cohort analysis using Danish registries from 1994-2018.
  • Inclusion of 1237 patients with ACM and 17,211 individuals with DCM.
  • Assessment of prognostic differences and mortality rates with and without AF, and following oral anticoagulation initiation.

Main Results:

  • Patients with ACM were younger, more often male, and had a greater cumulative 5-year mortality than DCM patients, irrespective of AF.
  • The prognosis associated with AF differed significantly between ACM and DCM.
  • Oral anticoagulation demonstrated similar mortality benefits in both ACM and DCM cohorts.

Conclusions:

  • Alcoholic cardiomyopathy (ACM) is associated with a worse prognosis compared to dilated cardiomyopathy (DCM).
  • Atrial fibrillation (AF) does not appear to be the primary driver of the worse prognosis in ACM.
  • Oral anticoagulation provides comparable risk reduction benefits for patients with ACM and DCM.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
25
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
18
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
32
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
46
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
13